| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.07B | +24.4% |
| Cost of Revenue | $380.6M | +24.5% |
| Gross Profit | $690.8M | +24.3% |
| R&D Expense | $223.0M | +31.4% |
| SG&A Expense | $200.5M | +85.7% |
| Operating Income | -$307.5M | -62.9% |
| Pre-tax Income | -$326.0M | +13.4% |
| Income Tax | -$55.9M | +8.0% |
| Net Income | -$270.1M | +14.5% |
| EPS (Basic) | -$0.54 | +95.8% |
| EPS (Diluted) | -$0.54 | +95.8% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $358.1M | +195.3% |
| Accounts Receivable | $335.0M | +31.9% |
| Current Assets | $850.7M | +66.0% |
| Total Assets | $7.60B | +2.5% |
| Current Liabilities | $643.3M | +11.9% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $751.3M | -58.4% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $70.6M | +166.3% |
| Capital Expenditures | $6.0M | +11.5% |
| Investing Cash Flow | -$35.6M | -22.8% |
| Financing Cash Flow | $202.0M | +389.5% |
| Free Cash Flow | $64.6M | +157.8% |
| $6.85B |
| +222.5% |